Industry Research Reports

Home > Reports > Medical Care > Total Parenteral Nutrition (TPN) Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Total Parenteral Nutrition (TPN) Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-11

Pages: 114 Pages

Report ld: 2639219

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Total Parenteral Nutrition (TPN) Solution was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Total Parenteral Nutrition (TPN) Solution was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Total Parenteral Nutrition (TPN) Solution was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Total Parenteral Nutrition (TPN) Solution was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Total Parenteral Nutrition (TPN) Solution include Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira) and Ostuka Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Total Parenteral Nutrition (TPN) Solution, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Total Parenteral Nutrition (TPN) Solution by region & country, by Type, and by Application.

The Total Parenteral Nutrition (TPN) Solution market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Total Parenteral Nutrition (TPN) Solution.

Market Segmentation

Report Metric
Details
Report Title
Total Parenteral Nutrition (TPN) Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Total Parenteral Nutrition (TPN) Solution Companies Covered
Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, Laboratorios Biogalenic, Laboratorios Finlay, Grifols International, Fresenius Kabi, Sichuan Kelun Pharmaceutical
Global Total Parenteral Nutrition (TPN) Solution Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Total Parenteral Nutrition (TPN) Solution Market, Segment by Type
Amino Acid-Dextrose Solution

Lipid Emulsions Solution
Global Total Parenteral Nutrition (TPN) Solution Market, Segment by Application
Hospital

Home
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Total Parenteral Nutrition (TPN) Solution manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Total Parenteral Nutrition (TPN) Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Total Parenteral Nutrition (TPN) Solution in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Total Parenteral Nutrition (TPN) Solution Product Introduction
    1.2 Global Total Parenteral Nutrition (TPN) Solution Market Size Forecast
    1.3 Total Parenteral Nutrition (TPN) Solution Market Trends & Drivers
        1.3.1 Total Parenteral Nutrition (TPN) Solution Industry Trends
        1.3.2 Total Parenteral Nutrition (TPN) Solution Market Drivers & Opportunity
        1.3.3 Total Parenteral Nutrition (TPN) Solution Market Challenges
        1.3.4 Total Parenteral Nutrition (TPN) Solution Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Total Parenteral Nutrition (TPN) Solution Players Revenue Ranking (2023)
    2.2 Global Total Parenteral Nutrition (TPN) Solution Revenue by Company (2019-2024)
    2.3 Key Companies Total Parenteral Nutrition (TPN) Solution Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Total Parenteral Nutrition (TPN) Solution Product Offered
    2.5 Key Companies Time to Begin Mass Production of Total Parenteral Nutrition (TPN) Solution
    2.6 Total Parenteral Nutrition (TPN) Solution Market Competitive Analysis
        2.6.1 Total Parenteral Nutrition (TPN) Solution Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Total Parenteral Nutrition (TPN) Solution Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Total Parenteral Nutrition (TPN) Solution as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Amino Acid-Dextrose Solution
        3.1.2 Lipid Emulsions Solution
    3.2 Global Total Parenteral Nutrition (TPN) Solution Sales Value by Type
        3.2.1 Global Total Parenteral Nutrition (TPN) Solution Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Total Parenteral Nutrition (TPN) Solution Sales Value, by Type (2019-2030)
        3.2.3 Global Total Parenteral Nutrition (TPN) Solution Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Home
    4.2 Global Total Parenteral Nutrition (TPN) Solution Sales Value by Application
        4.2.1 Global Total Parenteral Nutrition (TPN) Solution Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Total Parenteral Nutrition (TPN) Solution Sales Value, by Application (2019-2030)
        4.2.3 Global Total Parenteral Nutrition (TPN) Solution Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Total Parenteral Nutrition (TPN) Solution Sales Value by Region
        5.1.1 Global Total Parenteral Nutrition (TPN) Solution Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Total Parenteral Nutrition (TPN) Solution Sales Value by Region (2019-2024)
        5.1.3 Global Total Parenteral Nutrition (TPN) Solution Sales Value by Region (2025-2030)
        5.1.4 Global Total Parenteral Nutrition (TPN) Solution Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Total Parenteral Nutrition (TPN) Solution Sales Value, 2019-2030
        5.2.2 North America Total Parenteral Nutrition (TPN) Solution Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Total Parenteral Nutrition (TPN) Solution Sales Value, 2019-2030
        5.3.2 Europe Total Parenteral Nutrition (TPN) Solution Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Total Parenteral Nutrition (TPN) Solution Sales Value, 2019-2030
        5.4.2 Asia Pacific Total Parenteral Nutrition (TPN) Solution Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Total Parenteral Nutrition (TPN) Solution Sales Value, 2019-2030
        5.5.2 South America Total Parenteral Nutrition (TPN) Solution Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Total Parenteral Nutrition (TPN) Solution Sales Value, 2019-2030
        5.6.2 Middle East & Africa Total Parenteral Nutrition (TPN) Solution Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Total Parenteral Nutrition (TPN) Solution Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Total Parenteral Nutrition (TPN) Solution Sales Value
    6.3 United States
        6.3.1 United States Total Parenteral Nutrition (TPN) Solution Sales Value, 2019-2030
        6.3.2 United States Total Parenteral Nutrition (TPN) Solution Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Total Parenteral Nutrition (TPN) Solution Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Total Parenteral Nutrition (TPN) Solution Sales Value, 2019-2030
        6.4.2 Europe Total Parenteral Nutrition (TPN) Solution Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Total Parenteral Nutrition (TPN) Solution Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Total Parenteral Nutrition (TPN) Solution Sales Value, 2019-2030
        6.5.2 China Total Parenteral Nutrition (TPN) Solution Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Total Parenteral Nutrition (TPN) Solution Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Total Parenteral Nutrition (TPN) Solution Sales Value, 2019-2030
        6.6.2 Japan Total Parenteral Nutrition (TPN) Solution Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Total Parenteral Nutrition (TPN) Solution Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Total Parenteral Nutrition (TPN) Solution Sales Value, 2019-2030
        6.7.2 South Korea Total Parenteral Nutrition (TPN) Solution Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Total Parenteral Nutrition (TPN) Solution Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Total Parenteral Nutrition (TPN) Solution Sales Value, 2019-2030
        6.8.2 Southeast Asia Total Parenteral Nutrition (TPN) Solution Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Total Parenteral Nutrition (TPN) Solution Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Total Parenteral Nutrition (TPN) Solution Sales Value, 2019-2030
        6.9.2 India Total Parenteral Nutrition (TPN) Solution Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Total Parenteral Nutrition (TPN) Solution Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Eurofarma
        7.1.1 Eurofarma Profile
        7.1.2 Eurofarma Main Business
        7.1.3 Eurofarma Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
        7.1.4 Eurofarma Total Parenteral Nutrition (TPN) Solution Revenue (US$ Million) & (2019-2024)
        7.1.5 Eurofarma Recent Developments
    7.2 Corporacion De Laboratorios Farmaceuticos
        7.2.1 Corporacion De Laboratorios Farmaceuticos Profile
        7.2.2 Corporacion De Laboratorios Farmaceuticos Main Business
        7.2.3 Corporacion De Laboratorios Farmaceuticos Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
        7.2.4 Corporacion De Laboratorios Farmaceuticos Total Parenteral Nutrition (TPN) Solution Revenue (US$ Million) & (2019-2024)
        7.2.5 Corporacion De Laboratorios Farmaceuticos Recent Developments
    7.3 Baxter International Inc.
        7.3.1 Baxter International Inc. Profile
        7.3.2 Baxter International Inc. Main Business
        7.3.3 Baxter International Inc. Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
        7.3.4 Baxter International Inc. Total Parenteral Nutrition (TPN) Solution Revenue (US$ Million) & (2019-2024)
        7.3.5 Kelun Pharma Recent Developments
    7.4 Kelun Pharma
        7.4.1 Kelun Pharma Profile
        7.4.2 Kelun Pharma Main Business
        7.4.3 Kelun Pharma Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
        7.4.4 Kelun Pharma Total Parenteral Nutrition (TPN) Solution Revenue (US$ Million) & (2019-2024)
        7.4.5 Kelun Pharma Recent Developments
    7.5 B. Braun
        7.5.1 B. Braun Profile
        7.5.2 B. Braun Main Business
        7.5.3 B. Braun Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
        7.5.4 B. Braun Total Parenteral Nutrition (TPN) Solution Revenue (US$ Million) & (2019-2024)
        7.5.5 B. Braun Recent Developments
    7.6 Fresenius
        7.6.1 Fresenius Profile
        7.6.2 Fresenius Main Business
        7.6.3 Fresenius Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
        7.6.4 Fresenius Total Parenteral Nutrition (TPN) Solution Revenue (US$ Million) & (2019-2024)
        7.6.5 Fresenius Recent Developments
    7.7 Teva Pharmaceutical Industries
        7.7.1 Teva Pharmaceutical Industries Profile
        7.7.2 Teva Pharmaceutical Industries Main Business
        7.7.3 Teva Pharmaceutical Industries Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
        7.7.4 Teva Pharmaceutical Industries Total Parenteral Nutrition (TPN) Solution Revenue (US$ Million) & (2019-2024)
        7.7.5 Teva Pharmaceutical Industries Recent Developments
    7.8 Pfizer (Hospira)
        7.8.1 Pfizer (Hospira) Profile
        7.8.2 Pfizer (Hospira) Main Business
        7.8.3 Pfizer (Hospira) Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
        7.8.4 Pfizer (Hospira) Total Parenteral Nutrition (TPN) Solution Revenue (US$ Million) & (2019-2024)
        7.8.5 Pfizer (Hospira) Recent Developments
    7.9 Ostuka Pharmaceutical
        7.9.1 Ostuka Pharmaceutical Profile
        7.9.2 Ostuka Pharmaceutical Main Business
        7.9.3 Ostuka Pharmaceutical Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
        7.9.4 Ostuka Pharmaceutical Total Parenteral Nutrition (TPN) Solution Revenue (US$ Million) & (2019-2024)
        7.9.5 Ostuka Pharmaceutical Recent Developments
    7.10 Laboratorios Biogalenic
        7.10.1 Laboratorios Biogalenic Profile
        7.10.2 Laboratorios Biogalenic Main Business
        7.10.3 Laboratorios Biogalenic Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
        7.10.4 Laboratorios Biogalenic Total Parenteral Nutrition (TPN) Solution Revenue (US$ Million) & (2019-2024)
        7.10.5 Laboratorios Biogalenic Recent Developments
    7.11 Laboratorios Finlay
        7.11.1 Laboratorios Finlay Profile
        7.11.2 Laboratorios Finlay Main Business
        7.11.3 Laboratorios Finlay Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
        7.11.4 Laboratorios Finlay Total Parenteral Nutrition (TPN) Solution Revenue (US$ Million) & (2019-2024)
        7.11.5 Laboratorios Finlay Recent Developments
    7.12 Grifols International
        7.12.1 Grifols International Profile
        7.12.2 Grifols International Main Business
        7.12.3 Grifols International Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
        7.12.4 Grifols International Total Parenteral Nutrition (TPN) Solution Revenue (US$ Million) & (2019-2024)
        7.12.5 Grifols International Recent Developments
    7.13 Fresenius Kabi
        7.13.1 Fresenius Kabi Profile
        7.13.2 Fresenius Kabi Main Business
        7.13.3 Fresenius Kabi Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
        7.13.4 Fresenius Kabi Total Parenteral Nutrition (TPN) Solution Revenue (US$ Million) & (2019-2024)
        7.13.5 Fresenius Kabi Recent Developments
    7.14 Sichuan Kelun Pharmaceutical
        7.14.1 Sichuan Kelun Pharmaceutical Profile
        7.14.2 Sichuan Kelun Pharmaceutical Main Business
        7.14.3 Sichuan Kelun Pharmaceutical Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
        7.14.4 Sichuan Kelun Pharmaceutical Total Parenteral Nutrition (TPN) Solution Revenue (US$ Million) & (2019-2024)
        7.14.5 Sichuan Kelun Pharmaceutical Recent Developments

 8 Industry Chain Analysis
    8.1 Total Parenteral Nutrition (TPN) Solution Industrial Chain
    8.2 Total Parenteral Nutrition (TPN) Solution Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Total Parenteral Nutrition (TPN) Solution Sales Model
        8.5.2 Sales Channel
        8.5.3 Total Parenteral Nutrition (TPN) Solution Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Total Parenteral Nutrition (TPN) Solution Market Trends
    Table 2. Total Parenteral Nutrition (TPN) Solution Market Drivers & Opportunity
    Table 3. Total Parenteral Nutrition (TPN) Solution Market Challenges
    Table 4. Total Parenteral Nutrition (TPN) Solution Market Restraints
    Table 5. Global Total Parenteral Nutrition (TPN) Solution Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Total Parenteral Nutrition (TPN) Solution Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Total Parenteral Nutrition (TPN) Solution Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Total Parenteral Nutrition (TPN) Solution Product Type
    Table 9. Key Companies Time to Begin Mass Production of Total Parenteral Nutrition (TPN) Solution
    Table 10. Global Total Parenteral Nutrition (TPN) Solution Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Total Parenteral Nutrition (TPN) Solution as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Total Parenteral Nutrition (TPN) Solution Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Total Parenteral Nutrition (TPN) Solution Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Total Parenteral Nutrition (TPN) Solution Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Total Parenteral Nutrition (TPN) Solution Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Total Parenteral Nutrition (TPN) Solution Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Total Parenteral Nutrition (TPN) Solution Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Total Parenteral Nutrition (TPN) Solution Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Total Parenteral Nutrition (TPN) Solution Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Total Parenteral Nutrition (TPN) Solution Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Total Parenteral Nutrition (TPN) Solution Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Total Parenteral Nutrition (TPN) Solution Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Total Parenteral Nutrition (TPN) Solution Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Total Parenteral Nutrition (TPN) Solution Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Total Parenteral Nutrition (TPN) Solution Sales Value by Region (2019-2024) & (%)
    Table 27. Global Total Parenteral Nutrition (TPN) Solution Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Total Parenteral Nutrition (TPN) Solution Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Total Parenteral Nutrition (TPN) Solution Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Total Parenteral Nutrition (TPN) Solution Sales Value, (2025-2030) & (US$ Million)
    Table 31. Eurofarma Basic Information List
    Table 32. Eurofarma Description and Business Overview
    Table 33. Eurofarma Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Total Parenteral Nutrition (TPN) Solution Business of Eurofarma (2019-2024)
    Table 35. Eurofarma Recent Developments
    Table 36. Corporacion De Laboratorios Farmaceuticos Basic Information List
    Table 37. Corporacion De Laboratorios Farmaceuticos Description and Business Overview
    Table 38. Corporacion De Laboratorios Farmaceuticos Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Total Parenteral Nutrition (TPN) Solution Business of Corporacion De Laboratorios Farmaceuticos (2019-2024)
    Table 40. Corporacion De Laboratorios Farmaceuticos Recent Developments
    Table 41. Baxter International Inc. Basic Information List
    Table 42. Baxter International Inc. Description and Business Overview
    Table 43. Baxter International Inc. Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Total Parenteral Nutrition (TPN) Solution Business of Baxter International Inc. (2019-2024)
    Table 45. Baxter International Inc. Recent Developments
    Table 46. Kelun Pharma Basic Information List
    Table 47. Kelun Pharma Description and Business Overview
    Table 48. Kelun Pharma Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Total Parenteral Nutrition (TPN) Solution Business of Kelun Pharma (2019-2024)
    Table 50. Kelun Pharma Recent Developments
    Table 51. B. Braun Basic Information List
    Table 52. B. Braun Description and Business Overview
    Table 53. B. Braun Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Total Parenteral Nutrition (TPN) Solution Business of B. Braun (2019-2024)
    Table 55. B. Braun Recent Developments
    Table 56. Fresenius Basic Information List
    Table 57. Fresenius Description and Business Overview
    Table 58. Fresenius Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Total Parenteral Nutrition (TPN) Solution Business of Fresenius (2019-2024)
    Table 60. Fresenius Recent Developments
    Table 61. Teva Pharmaceutical Industries Basic Information List
    Table 62. Teva Pharmaceutical Industries Description and Business Overview
    Table 63. Teva Pharmaceutical Industries Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Total Parenteral Nutrition (TPN) Solution Business of Teva Pharmaceutical Industries (2019-2024)
    Table 65. Teva Pharmaceutical Industries Recent Developments
    Table 66. Pfizer (Hospira) Basic Information List
    Table 67. Pfizer (Hospira) Description and Business Overview
    Table 68. Pfizer (Hospira) Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Total Parenteral Nutrition (TPN) Solution Business of Pfizer (Hospira) (2019-2024)
    Table 70. Pfizer (Hospira) Recent Developments
    Table 71. Ostuka Pharmaceutical Basic Information List
    Table 72. Ostuka Pharmaceutical Description and Business Overview
    Table 73. Ostuka Pharmaceutical Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Total Parenteral Nutrition (TPN) Solution Business of Ostuka Pharmaceutical (2019-2024)
    Table 75. Ostuka Pharmaceutical Recent Developments
    Table 76. Laboratorios Biogalenic Basic Information List
    Table 77. Laboratorios Biogalenic Description and Business Overview
    Table 78. Laboratorios Biogalenic Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Total Parenteral Nutrition (TPN) Solution Business of Laboratorios Biogalenic (2019-2024)
    Table 80. Laboratorios Biogalenic Recent Developments
    Table 81. Laboratorios Finlay Basic Information List
    Table 82. Laboratorios Finlay Description and Business Overview
    Table 83. Laboratorios Finlay Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Total Parenteral Nutrition (TPN) Solution Business of Laboratorios Finlay (2019-2024)
    Table 85. Laboratorios Finlay Recent Developments
    Table 86. Grifols International Basic Information List
    Table 87. Grifols International Description and Business Overview
    Table 88. Grifols International Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Total Parenteral Nutrition (TPN) Solution Business of Grifols International (2019-2024)
    Table 90. Grifols International Recent Developments
    Table 91. Fresenius Kabi Basic Information List
    Table 92. Fresenius Kabi Description and Business Overview
    Table 93. Fresenius Kabi Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Total Parenteral Nutrition (TPN) Solution Business of Fresenius Kabi (2019-2024)
    Table 95. Fresenius Kabi Recent Developments
    Table 96. Sichuan Kelun Pharmaceutical Basic Information List
    Table 97. Sichuan Kelun Pharmaceutical Description and Business Overview
    Table 98. Sichuan Kelun Pharmaceutical Total Parenteral Nutrition (TPN) Solution Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Total Parenteral Nutrition (TPN) Solution Business of Sichuan Kelun Pharmaceutical (2019-2024)
    Table 100. Sichuan Kelun Pharmaceutical Recent Developments
    Table 101. Key Raw Materials Lists
    Table 102. Raw Materials Key Suppliers Lists
    Table 103. Total Parenteral Nutrition (TPN) Solution Downstream Customers
    Table 104. Total Parenteral Nutrition (TPN) Solution Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
    Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Total Parenteral Nutrition (TPN) Solution Product Picture
    Figure 2. Global Total Parenteral Nutrition (TPN) Solution Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Total Parenteral Nutrition (TPN) Solution Sales Value (2019-2030) & (US$ Million)
    Figure 4. Total Parenteral Nutrition (TPN) Solution Report Years Considered
    Figure 5. Global Total Parenteral Nutrition (TPN) Solution Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Total Parenteral Nutrition (TPN) Solution Revenue in 2023
    Figure 7. Total Parenteral Nutrition (TPN) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Amino Acid-Dextrose Solution Picture
    Figure 9. Lipid Emulsions Solution Picture
    Figure 10. Global Total Parenteral Nutrition (TPN) Solution Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Total Parenteral Nutrition (TPN) Solution Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital
    Figure 13. Product Picture of Home
    Figure 14. Global Total Parenteral Nutrition (TPN) Solution Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Total Parenteral Nutrition (TPN) Solution Sales Value Market Share by Application, 2023 & 2030
    Figure 16. North America Total Parenteral Nutrition (TPN) Solution Sales Value (2019-2030) & (US$ Million)
    Figure 17. North America Total Parenteral Nutrition (TPN) Solution Sales Value by Country (%), 2023 VS 2030
    Figure 18. Europe Total Parenteral Nutrition (TPN) Solution Sales Value (2019-2030) & (US$ Million)
    Figure 19. Europe Total Parenteral Nutrition (TPN) Solution Sales Value by Country (%), 2023 VS 2030
    Figure 20. Asia Pacific Total Parenteral Nutrition (TPN) Solution Sales Value (2019-2030) & (US$ Million)
    Figure 21. Asia Pacific Total Parenteral Nutrition (TPN) Solution Sales Value by Country (%), 2023 VS 2030
    Figure 22. South America Total Parenteral Nutrition (TPN) Solution Sales Value (2019-2030) & (US$ Million)
    Figure 23. South America Total Parenteral Nutrition (TPN) Solution Sales Value by Country (%), 2023 VS 2030
    Figure 24. Middle East & Africa Total Parenteral Nutrition (TPN) Solution Sales Value (2019-2030) & (US$ Million)
    Figure 25. Middle East & Africa Total Parenteral Nutrition (TPN) Solution Sales Value by Country (%), 2023 VS 2030
    Figure 26. Key Countries/Regions Total Parenteral Nutrition (TPN) Solution Sales Value (%), (2019-2030)
    Figure 27. United States Total Parenteral Nutrition (TPN) Solution Sales Value, (2019-2030) & (US$ Million)
    Figure 28. United States Total Parenteral Nutrition (TPN) Solution Sales Value by Type (%), 2023 VS 2030
    Figure 29. United States Total Parenteral Nutrition (TPN) Solution Sales Value by Application (%), 2023 VS 2030
    Figure 30. Europe Total Parenteral Nutrition (TPN) Solution Sales Value, (2019-2030) & (US$ Million)
    Figure 31. Europe Total Parenteral Nutrition (TPN) Solution Sales Value by Type (%), 2023 VS 2030
    Figure 32. Europe Total Parenteral Nutrition (TPN) Solution Sales Value by Application (%), 2023 VS 2030
    Figure 33. China Total Parenteral Nutrition (TPN) Solution Sales Value, (2019-2030) & (US$ Million)
    Figure 34. China Total Parenteral Nutrition (TPN) Solution Sales Value by Type (%), 2023 VS 2030
    Figure 35. China Total Parenteral Nutrition (TPN) Solution Sales Value by Application (%), 2023 VS 2030
    Figure 36. Japan Total Parenteral Nutrition (TPN) Solution Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Japan Total Parenteral Nutrition (TPN) Solution Sales Value by Type (%), 2023 VS 2030
    Figure 38. Japan Total Parenteral Nutrition (TPN) Solution Sales Value by Application (%), 2023 VS 2030
    Figure 39. South Korea Total Parenteral Nutrition (TPN) Solution Sales Value, (2019-2030) & (US$ Million)
    Figure 40. South Korea Total Parenteral Nutrition (TPN) Solution Sales Value by Type (%), 2023 VS 2030
    Figure 41. South Korea Total Parenteral Nutrition (TPN) Solution Sales Value by Application (%), 2023 VS 2030
    Figure 42. Southeast Asia Total Parenteral Nutrition (TPN) Solution Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Total Parenteral Nutrition (TPN) Solution Sales Value by Type (%), 2023 VS 2030
    Figure 44. Southeast Asia Total Parenteral Nutrition (TPN) Solution Sales Value by Application (%), 2023 VS 2030
    Figure 45. India Total Parenteral Nutrition (TPN) Solution Sales Value, (2019-2030) & (US$ Million)
    Figure 46. India Total Parenteral Nutrition (TPN) Solution Sales Value by Type (%), 2023 VS 2030
    Figure 47. India Total Parenteral Nutrition (TPN) Solution Sales Value by Application (%), 2023 VS 2030
    Figure 48. Total Parenteral Nutrition (TPN) Solution Industrial Chain
    Figure 49. Total Parenteral Nutrition (TPN) Solution Manufacturing Cost Structure
    Figure 50. Channels of Distribution (Direct Sales, and Distribution)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation

Description

The global market for Total Parenteral Nutrition (TPN) Solution was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Total Parenteral Nutrition (TPN) Solution was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Total Parenteral Nutrition (TPN) Solution was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Total Parenteral Nutrition (TPN) Solution was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Total Parenteral Nutrition (TPN) Solution include Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira) and Ostuka Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Total Parenteral Nutrition (TPN) Solution, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Total Parenteral Nutrition (TPN) Solution by region & country, by Type, and by Application.

The Total Parenteral Nutrition (TPN) Solution market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Total Parenteral Nutrition (TPN) Solution.

Market Segmentation